IgE CH3 peptide vaccine
US9249233B2 · kind B2 · utility
0Cited by
21References
17Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 25, 2014 |
| Grant date | Feb 2, 2016 |
| Priority date | — |
| Expiry date | Jul 29, 2034 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/868
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to the provision of novel immunogens comprising an antigenic IgE peptide preferably linked to an immunogenic carrier, compositions comprising the immunogens, and methods for the prevention, treatment or alleviation of IgE-mediated disorders. The invention further relates to methods for production of these medicaments, immunogenic compositions and pharmaceutical compositing thereof and their use in medicine.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.